Anti tuberculosis
Showing 1 - 25 of >10,000
CD4/CD8+ Interferon Gamma Release Assay for Monitoring
Active, not recruiting
- Tuberculosis
- Interferon gamma release assay (IGRA)
-
Milano, ItalyIRCCS San Raffaele Scientific Institute
Feb 13, 2023
Tuberculosis, Drug Induced Liver Injury, Hepatitis Trial in Bangkok (N acetyl cysteine)
Recruiting
- Tuberculosis
- +2 more
- N acetyl cysteine
-
Bangkok, ThailandFaculty of Medicine, Siriraj Hospital
Feb 12, 2023
Tuberculous Lymphadenitis Trial in Taipei (Prednisolone, standard anti-tuberculosis agents)
Recruiting
- Tuberculous Lymphadenitis
- Prednisolone
- standard anti-tuberculosis agents
-
Taipei, TaiwanNational Taiwan University Hospital
May 17, 2023
Tuberculosis Infection Trial in Zurich (Nivaquine ® (Chloroquine))
Recruiting
- Tuberculosis Infection
- Nivaquine ® (Chloroquine)
-
Zurich, SwitzerlandClinical Trial Center
Jun 28, 2022
Tuberculosis, Pulmonary Trial in Houston (Azacitidine Injection)
Not yet recruiting
- Tuberculosis, Pulmonary
- Azacitidine Injection
-
Houston, TexasHarris Health System - Ben Taub Hospital
Sep 1, 2022
Adequacy of New Pediatric Isoniazid/Rifampin/Pyrazinamide Tablet
Recruiting
- Tuberculosis
- +2 more
- Observational PK study
-
Kumasi, GhanaKwame Nkrumah University of Science and Technology
Dec 21, 2022
Multi-drug Resistant Tuberculosis Trial in China (18-month regimen containing 6 anti-TB drugs)
Completed
- Multi-drug Resistant Tuberculosis
- 18-month regimen containing 6 anti-TB drugs
-
Beijing, China
- +19 more
Oct 10, 2022
Kidney Transplant Infection, Tuberculosis, Isoniazid Toxicity Trial (Isoniazid, without any additional anti-tuberculosis
Not yet recruiting
- Kidney Transplant Infection
- +2 more
- Isoniazid
- without any additional anti-tuberculosis treatment
- (no location specified)
Mar 21, 2022
Tuberculosis Trial in Phnom Penh (ACF with a seed-and-recruit model, ACF targeting household and neighborhood contacts, ACF
Completed
- Tuberculosis
- ACF with a seed-and-recruit model
- +3 more
-
Phnom Penh, Cambodia
- +2 more
Nov 26, 2022
MDR-TB Trial in Worldwide (Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline), Moxifloxacin, Clofazimine)
Active, not recruiting
- MDR-TB
- Regimen A locally-used WHO-approved MDR-TB regimen (2011 guideline)
- +9 more
-
Addis Ababa, Ethiopia
- +12 more
Oct 12, 2022
Tuberculous Uveitis Trial in Jakarta Pusat (Anti Tuberculosis Drug, Prednisone tablet)
Enrolling by invitation
- Tuberculous Uveitis
- Anti Tuberculosis Drug
- Prednisone tablet
-
Jakarta Pusat, DKI Jakarta, IndonesiaCipto Mangunkusumo National Central General Hospital
Sep 12, 2021
Intracellular TFV-DP and FTC-TP in HIV-infected Adolescents
Recruiting
- Human Immunodeficiency Virus (HIV)
- +2 more
- Observational PK study
-
Kumasi, GhanaKwame Nkrumah University of Science and Technology
Jun 13, 2022
Contributing Factors for Poor HIV Treatment Response in TB/HIV
Recruiting
- Tuberculosis
- +2 more
- Observational study
-
Kumasi, GhanaKwame Nkrumah University of Science and Technology
Mar 23, 2022
Tuberculosis, HIV I Infection, Sepsis Trial in Sanya Juu, Mbarara (Immediate anti-TB therapy, Sepsis-specific dose anti-TB
Recruiting
- Tuberculosis
- +2 more
- Immediate anti-TB therapy
- Sepsis-specific dose anti-TB therapy
-
Sanya Juu, Tanzania
- +1 more
Dec 10, 2021
Tuberculosis, Malnutrition, Helminth Infection Trial in Pondicherry (Nutritional Supplementation Meal, Multivitamin,
Enrolling by invitation
- Tuberculosis
- +2 more
- Nutritional Supplementation Meal
- +2 more
-
Pondicherry, Tamil Nadu, IndiaJawaharlal Institute of Postgraduate Medical Education and Resea
May 3, 2022
HIV, Tuberculosis Trial in Worldwide (Levonorgestrel (LNG))
Completed
- HIV Infections
- Tuberculosis
- Levonorgestrel (LNG)
-
Chicago, Illinois
- +17 more
Dec 22, 2021
Tuberculosis, Pulmonary, Tuberculosis Trial in Ile Ife, Birmingham (Atorvastatin with standard anti tuberculosis drugs, Anti
Unknown status
- Tuberculosis, Pulmonary
- Tuberculosis
- Atorvastatin with standard anti tuberculosis drugs
- Anti tuberculosis drugs only
-
Ile Ife, Osun, Nigeria
- +1 more
Feb 5, 2021
Anti-tuberculosis Drugs in Gastrectomized Patients
Completed
- Tuberculosis
- +2 more
- standard first line anti-TB drugs
-
Goyang-si, Gyeonggi-do, Korea, Republic ofRespiratory Clinic, National Cancer Center
Sep 24, 2020
Tuberculosis, Drug-resistant Tuberculosis, Isoniazid Resistant Tuberculosis (Disorder) Trial in Chennai (High dose isoniazid)
Completed
- Tuberculosis
- +2 more
- High dose isoniazid
-
Chennai, Tamil Nadu, IndiaNational Institute for Research on Tuberculosis
Oct 13, 2020
TB-CAPT MTB/XDR Study
Recruiting
- Tuberculosis
- +2 more
- Xpert MTB/XDR
-
Cape Town, South Africa
- +1 more
May 17, 2021
HIV, AIDS Trial in Phnom Penh (Community-based ART delivery (CAD), ART multi-month dispensing (MMD))
Recruiting
- HIV Infections
- AIDS
- Community-based ART delivery (CAD)
- ART multi-month dispensing (MMD)
-
Phnom Penh, Cambodia
- +2 more
Aug 31, 2021
Tuberculosis Drug Levels in Diabetics
Not yet recruiting
- Tuberculosis
- Diabetes Mellitus
- Measurement of tuberculosis medications level
- (no location specified)
Apr 14, 2021
Multiple Sclerosis Trial in Rome (Bacille Calmette-Guerin vaccine, Placebo)
Recruiting
- Multiple Sclerosis
- Bacille Calmette-Guerin vaccine
- Placebo
-
Rome, ItalyCenter for Experimental Neurological Therapies (CENTERS), S. And
Jun 4, 2021
HIV, Tuberculosis Trial in Worldwide (Efavirenz (EFV), Rifampin-containing anti-TB therapy)
Completed
- HIV Infections
- Tuberculosis
- Efavirenz (EFV)
- Rifampin-containing anti-TB therapy
-
Pune, Maharashtra, India
- +6 more
Oct 28, 2021
Paradoxical Reactions in Non Immuno-compromized Extrapulmonary
Completed
- Extrapulmonary Tuberculosis
- Genetic analysis
- +3 more
-
Paris, FranceGeorges Pompidou Hospital
May 27, 2021